Table 2 Efficacy outcomes at the start and after 12 months of treatment in the SMART (* Budesonide/formoterol maintenance and reliever therapy) and Usual Care groups and efficacy outcomes of SMART compared with Usual Care after 12 months of treatment

From: Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control

Back to article page